Updated 12/09/22
I receive questions occasionally and want to create this document, which is available to the public, to address any concerns about potential conflicts of interest as it relates to 420 Investor. I earned the designation of Chartered Financial Analyst (CFA) in 1997 and am committed to transparency and displaying the highest levels of integrity. I adhere to the CFA Institute's Code of Ethics and Standards of Professional Conduct.
With respect to personal trading, I have not ever nor will I invest in publicly-traded cannabis stocks. While this may seem disappointing to some, my intent is to avoid anything that would threaten my objectivity. More importantly, doing so would put me in a position of potentially "front-running" subscribers.
As I have previously indicated, in the event that I enter into any consulting arrangements with private companies, I will disclose the nature and, if possible, the name of any such relationships.
While I have no current arrangements to refer accredited investors to companies seeking capital, I may do so in the future. If so, I will disclose the nature of my compensation.
I have published at Seeking Alpha, where I am typically compensated at a rate of $0.01 per page-view, though there are flat-fee arrangements as well that can range from $150 to $500. SA is a platform that allows individual contributors to publish content - I am in no way an "employee" of SA.
I had consulting relationships with investment management firms, but, at the time, these relationships covered stocks that are entirely outside the cannabis space. Should I provide cannabis-related research to institutional investors in the future, I will disclose it.
I am not a registered investment advisor. In no way should anyone infer that I am providing individual investment advice. 420 ...